| Subject: cancer |
Author:
lee cannon
|
[
Next Thread |
Previous Thread |
Next Message |
Previous Message
]
Date Posted: 15:28:49 11/24/06 Fri
In reply to:
Ross
's message, "Transfer Factor used for Cancer Patients" on 11:44:03 12/11/04 Sat
>Transfer Factor is a food supplement !
>
>==============================
>Transfer Factor and Cancer
>Dr. See Abstracts
>-------------------------------------------------------
>-----------
>
>The study that Dr Darryl See carried out on the 20
>cancer patients that we have talked about and listened
>to from the conference calls has been published . 16
>out of the 20 late stage (stage IV) cancer patients
>were alive and in remission after the 6 month study
>(see below for the abstract of the publication).
>
>We have subsequently heard from Dr Darryl that at 8
>months and later an update from Dr Foo that at 12
>months the 16 patients were still alive and in
>remission or getting better.
>
>Dr Darryl See was very excited to use Transfer Factor
>Plus which he found to have "unprecedented" and very
>exciting immune boosting and modulating properties.
>The Transfer Factor plus had raised the NK cell to the
>extent that it was 500 % higher than the next highest
>product. In his conference call he said he chose to
>give Transfer Factor the "most severe test", and chose
>end stage cancer patients to further study Tranfer
>Factor plus. In the study he used some additional
>nutritional supplement to support the patients.
>
>
>**********
>
>Immunol Invest 2002 May;31(2):137-53
>
>Increased tumor necrosis factor alpha (TNF-alpha) and
>natural killer cell (NK) function using an integrative
>approach in late stage cancers.
>
>See D, Mason S, Roshan R.
>
>Center for Advanced Medicine, Encinitias, California
>92024, USA.
>
>Natural products may increase cytotoxic activity of
>Natural Killer Cells (NK) Tumor Necrosis Factor alpha
>(TNF-alpha) while decreasing DNA damage in patients
>with late-stage cancer. Pilot studies have suggested
>that a combination of Nutraceuticals can raise NK cell
>function and TNF-alpha alpha activity and result in
>improved clinical outcomes in patients with late stage
>cancer. The objective of the study is to determine if
>Nutraceuticals can significantly raise NK function and
>TNF levels in patients with late stage cancer. After
>informed consent was obtained, 20 patients with stage
>IV, end-stage cancer were evaluated (one bladder, five
>breast, two prostate, one neuroblastoma, two non-small
>cell lung, three colon, 1 mesothelioma, two lymphoma,
>one ovarian, one gastric, one osteosarcoma). Transfer
>Factor Plus (TFP+, 3 tablets 3 times per day), IMUPlus
>(non denatured milk whey protein, 40 gm/day);
>Intravenous (50 to 100 gm/day) and oral (1-2 gm/day)
>ascorbic acid; Agaricus Blazeii Murill teas (10
>gm/day); Immune Modulator Mix (a combination of
>vitamin, minerals, antioxidants and immune-enhancing
>natural products); nitrogenated soy extract (high
>levels of genistein and dadzein) and Andrographis
>Paniculata (500 mg twice, daily) were used. Baseline
>NK function by standard 4 h 51Cr release assay and TNF
>alpha and receptor levels were measured by ELISA from
>resting and phytohemagglutinin (PHA) stimulated
>adherent and non-adherent Peripheral Blood Mononuclear
>Cell (PBMC). Total mercaptans and glutathione in
>plasma were taken and compared to levels measured 6
>months later. Complete blood counts and chemistry
>panels were routinely monitored. As of a mean of 6
>months, 16/20 patients were still alive. The 16
>survivors had significantly higher NK function than
>baseline (p < .01 for each) and TNF-alpha levels in
>all four cell populations studied (p < .01 for each).
>Total mercaptans (p < .01) and TNF-alpha receptor
>levels were significantly reduced (p < .01). It was
>also observed that hemoglobin, hematocrit and
>glutathione levels were significantly elevated. The
>only toxicity noted was occasional diarrhea and
>nausea. The quality of life improved for all survivors
>by SF-36 form evaluation. An aggressive combination of
>immunoactive Nutraceuticals was effective in
>significantly increasing NK function, other immune
>parameters and hemoglobin from PBMC or plasma in
>patients with late stage cancers. Nutraceutical
>combinations may be effective in late stage cancers.
>Clinical outcomes evaluations are ongoing.
>
>INCREASED TUMOR NECROSIS FACTOR ALPHA AND NK CELL
>FUNCTION
>USING AN INTEGRATIVE APPROACH IN LATE STAGE CANCERS
>PATIENT DEMOGRAPHICS PATIENT REGIME INCLUDED RESULTS
>AFTER SIX MONTHS
>Twenty patients
>Average age: 49.3
>All stage 4 cancers
>12 males, 8 females
>Prognosis from physician: 3.7 months to live Transfer
>Factor Plus, Beta Glucans, soy
>extract, digestive enzymes, vegetarian,
>low-sugar diet, hyperthermia and more. Average Tumor
>Necrosis Factor alpha
>(TNF) increased from 12.4 to 1287.5
>Average increase in NK cell function:
>6.4 to 27.6
>
>=====================
>Listen to the short presentation here....
>
>http://www.globalsuccess4life.com/movie/flash2_3.swf
>
>and you decide!
>
>Read and understand the greatest findings of the
>century !
>- www.transferfactorinstitute.com
>- www.transferfactorresearch.com
>- http://www.professionalnetworkers.com
>http://www.geocities.com/forlife4malaysia/
>- www.4life.com.my
>- www.4life.com
>- My UPLINE website: http://sheridin.my4life.com/
>
>M.Rosman
>Malaysia
>Email: mrosman@streamyx.com
>HP: +60 19 913 7172
[
Next Thread |
Previous Thread |
Next Message |
Previous Message
]
| |
Feedback: 